| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
major histocompatibility complex, class II, DR beta 1 | 0.333 | 0.923 | 1.1E-03 |
|
disease | 0.500 | None | 0.946 | 5 | 0 | 1988 | 2020 | ||||||||
|
insulin | 0.445 | 0.923 | 0.30 |
|
disease | 0.700 | None | 0.969 | 4 | 0 | 1982 | 2020 | ||||||||
|
cytotoxic T-lymphocyte associated protein 4 | 0.369 | 0.923 | 0.94 |
|
disease | 0.100 | None | 0.882 | 4 | 0 | 1996 | 2019 | ||||||||
|
interleukin 6 | 0.248 | 0.962 | 0.32 |
|
disease | 0.400 | None | 0.895 | 3 | 0 | 1993 | 2020 | ||||||||
|
tumor necrosis factor | 0.231 | 0.962 | 0.80 |
|
disease | 0.400 | None | 0.950 | 3 | 0 | 1989 | 2020 | ||||||||
|
major histocompatibility complex, class II, DQ beta 1 | 0.407 | 0.885 | 8.9E-03 |
|
disease | 0.500 | None | 0.960 | 3 | 0 | 1989 | 2019 | ||||||||
|
interleukin 10 | 0.281 | 0.923 | 5.9E-03 |
|
disease | 0.500 | None | 0.927 | 2 | 0 | 1998 | 2020 | ||||||||
|
interleukin 18 | 0.365 | 0.923 | 3.1E-02 |
|
disease | 0.100 | None | 0.783 | 2 | 0 | 2001 | 2017 | ||||||||
|
major histocompatibility complex, class II, DQ alpha 1 | 0.416 | 0.846 | 2.4E-02 |
|
disease | 0.500 | None | 0.948 | 2 | 0 | 1988 | 2019 | ||||||||
|
protein tyrosine phosphatase non-receptor type 22 | 0.438 | 0.846 | 3.5E-21 |
|
disease | 0.900 | None | 0.945 | 2 | 0 | 2004 | 2020 | ||||||||
|
neuronal differentiation 1 | 0.543 | 0.808 | 0.77 |
|
disease | 0.300 | None | 0.727 | 2 | 0 | 1997 | 2006 | ||||||||
|
superoxide dismutase 1 | 0.379 | 0.962 | 0.18 |
|
disease | 0.070 | None | 1.000 | 1 | 0 | 2007 | 2019 | ||||||||
|
solute carrier family 2 member 1 | 0.388 | 0.808 | 0.99 |
|
disease | 0.090 | None | 0.889 | 1 | 0 | 1992 | 2019 | ||||||||
|
C-X-C motif chemokine ligand 12 | 0.379 | 0.846 | 0.12 |
|
disease | 0.100 | None | 0.900 | 1 | 0 | 2001 | 2019 | ||||||||
|
regenerating family member 1 beta | 0.716 | 0.308 | 2.0E-06 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2002 | 2002 | ||||||||
|
betacellulin | 0.644 | 0.577 | 6.2E-02 |
|
disease | 0.020 | None | 1.000 | 1 | 0 | 2006 | 2014 | ||||||||
|
adiponectin, C1Q and collagen domain containing | 0.376 | 0.885 | 4.6E-09 |
|
disease | 0.100 | None | 0.962 | 1 | 0 | 2004 | 2019 | ||||||||
|
CD14 molecule | 0.392 | 0.885 | 4.9E-05 |
|
disease | 0.070 | None | 1.000 | 1 | 0 | 1998 | 2017 | ||||||||
|
CD1d molecule | 0.532 | 0.769 | 1.9E-06 |
|
disease | 0.020 | None | 1.000 | 1 | 0 | 2004 | 2005 | ||||||||
|
vitamin D receptor | 0.352 | 0.885 | 1.7E-05 |
|
disease | 0.100 | None | 0.930 | 1 | 0 | 1997 | 2019 | ||||||||
|
tumor protein p53 | 0.236 | 0.962 | 0.53 |
|
disease | 0.080 | None | 1.000 | 1 | 0 | 2008 | 2018 | ||||||||
|
superoxide dismutase 2 | 0.379 | 0.923 | 0.15 |
|
disease | 0.090 | None | 1.000 | 1 | 0 | 1993 | 2019 | ||||||||
|
toll like receptor 4 | 0.321 | 0.962 | 4.6E-09 |
|
disease | 0.090 | None | 0.889 | 1 | 0 | 2004 | 2020 | ||||||||
|
toll like receptor 2 | 0.361 | 0.923 | 1.0E-06 |
|
disease | 0.070 | None | 0.857 | 1 | 0 | 2004 | 2020 | ||||||||
|
transforming growth factor beta 1 | 0.287 | 0.962 | 3.7E-02 |
|
disease | 0.100 | None | 1.000 | 1 | 0 | 2000 | 2019 |